Clinical Trials Directory

Trials / Unknown

UnknownNCT00815971

Mutations in the Epidermal Growth Factor Receptor(EGFR) Gene in Non-Small Cell Lung Carcinoma (NSCLC) and the Relation to Response of Treatment With Erlotinib

Status
Unknown
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Aarhus University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Recently it has been suggested that specific mutations in the EGFR gene in lung cancer patients is associated with response to a novel drug targeting the EGF system. Recent research also indicates that there is a possible association to the degree of aggressiveness of the disease. The importance of these mutations is controversial, because the data are based on small studies with highly selected patients. In this project the investigators want to study the types and frequencies of EGFR mutations in both untreated and treated patients in a systematic manner and relate this to survival. The thorough registration of patient data in DK enables us to create a strong The investigators expect this knowledge to be of greatest importance for future rational use of drugs targeting the EGF receptors.

Detailed description

Aim: 1. To establish a method for identifying the mutations in the EGFR gene in small clinical samples from lung cancer patients. 2. In a retrospective study(n=500) relate survival to the frequency and types of mutations in the EGFR gene in a Danish population of patients with advanced, inoperable non small cell lung cancer (NSCLC) diagnosed prior to the introduction of treatment directed towards EGFR. 3. In a prospective study (n=300), to identify the mutations in the EGFR gene in patients treated with erlotinib, a tyrosine kinase inhibitor targeting the EGFR. Presence of mutations will be related to the expression of other parts of the EGF system, to mutations in the gene coding for K-RAS and to treatment response.

Conditions

Timeline

Start date
2008-05-01
Primary completion
2011-05-01
Completion
2011-05-01
First posted
2008-12-31
Last updated
2008-12-31

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT00815971. Inclusion in this directory is not an endorsement.